In a new study, patients with 4 types of obesity-related cancer who were taking a GLP-1 medication were significantly less likely to see their cancer progress to stage 4.
Health News is provided as a service to San Andreas Pharmacy site users by HealthDay. San Andreas Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.